GLP-1 receptor agonists mimic a natural gut hormone called glucagon-like peptide 1 (GLP-1 for short)
Finally, emerging evidence indicates that chitosan-based carriers (l-serinemodified chitosan) can exploit kidney injury molecule-1 (KIM1), a phosphatidylserine receptor markedly upregulated on the apical membrane of injured proximal tubular epithelial cells [90], to achieve active, injury-selective drug delivery [91]
The primary underlying pathomechanism is most likely a decreased hepatic GHR expression related to insulin deficiency, resulting in GH-resistance and impaired hepatic IGF-1 synthesis, which stimulates pituitary GH-secretion by a feedback mechanism [188, 189]
However, it also produces some direct and indirect side effects
They may also have to convert the dosage into different measurements, says King, who is medical director of the Maryland Poison Center